Provided By GlobeNewswire
Last update: Nov 12, 2024
Upcoming oral presentation for the ALLOHATM Phase 1 heme trial at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
TSCAN THERAPEUTICS INC
NASDAQ:TCRX (2/21/2025, 8:00:01 PM)
2.17
-0.02 (-0.91%)
Find more stocks in the Stock Screener